Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

MNG351

6c68682e-0ad7-5d78-852d-e587ecf7b764

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

No GSVA scores available for this sample.

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

8 twins match this tumor's tissue · 2 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1MNG804
mng-umap@100
0.820
2MNG433
mng-umap@100
0.800
3X3cd3fbb2.8eb1.4fd0.ae5f.c940ae00e311
lung-landscapes@6
cohortA10.788
4MNG73
mng-umap@100
0.782
5SRR8943026
bladder-landscape@3
0.773
6TCGA-OR-A5LN-01
acc-tcga-pancan-2018@2018
Adrenocortical CarcinomaAdrenocortical Carcinoma, Usual Type0.750
7SRR27320680
colon-landscapes@1
0.748
8TCGA-78-7539-01A-11R-2066-07
lung-landscapes@6
cohortA10.748
9SRR8526721
lung-landscapes@6
cohortA10.736
10EPT0525
medullo-epn-umap@date-based
EPNPosterior Fossa EPN0.732

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 21 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
INTERFERON_ALPHA_RESPONSE0.641Inavolisib— uncovered
INTERFERON_GAMMA_RESPONSE0.501Idelalisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.422Remibrutinib— uncovered
ALLOGRAFT_REJECTION0.366Idelalisib— uncovered
IL6_JAK_STAT3_SIGNALING0.300Inavolisib— uncovered
DNA_REPAIR0.256Idelalisib— uncovered
PEROXISOME0.181Idelalisib— uncovered
ADIPOGENESIS0.169Inavolisib— uncovered
COMPLEMENT0.169Inavolisib— uncovered
REACTIVE_OXYGEN_SPECIES_PATHWAY0.164Inavolisib— uncovered
PROTEIN_SECRETION0.151Remibrutinib— uncovered
INFLAMMATORY_RESPONSE0.138Idelalisib— uncovered
PI3K_AKT_MTOR_SIGNALING0.133Inavolisib— uncovered
FATTY_ACID_METABOLISM0.130Inavolisib— uncovered
KRAS_SIGNALING_UP0.096Inavolisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.072Inavolisib— uncovered
P53_PATHWAY0.064Idelalisib— uncovered
HEDGEHOG_SIGNALING0.032Inavolisib— uncovered
UV_RESPONSE_DN0.030Inavolisib— uncovered
BILE_ACID_METABOLISM0.023Inavolisib— uncovered